Tradestie Institutional Equity Comparison Engine

EQ vs INMB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EQ Overall Edge

EQ Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Equillium, Inc. Common Stock (EQ) driven by superior Valuation, Momentum & Technical while INMB counters with relative strength in Options & Structure. Fundamentally, EQ trades at 1.5x Forward P/E with 0.0% operating margin (-52.3% YoY revenue) versus INMB at N/M Forward P/E and 0.0% operating margin (+257.1% YoY). In options structure, EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against INMB sits in BREAKDOWN (61st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EQ
EQ 1.5x vs INMB N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin 0.0% vs 0.0% ยท YoY -52.3% vs +257.1%
Momentum & Technical Winner EQ
1Y +12.0% vs -40.4% ยท 52W Pos 11% vs 0%
Options & Structure Winner INMB
UNCLASSIFIED (100th %ile IV) vs BREAKDOWN (61st %ile IV)
EQ NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap $90.6M
1M Return -21.13%
1Y Return +12.0%
Forward P/E 1.5x
Unified AI Score
48.0 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 63.0 Mom 60.0
INMB NASDAQ
INmune Bio Inc. Common stock
Biological Products, (No Disgnostic Substances)
$0.89
-13.19% 1D
Market Cap $31.9M
1M Return -44.47%
1Y Return -40.39%
Forward P/E N/M
Unified AI Score
45.4 / 100 HOLD
Tech 30.0 Fund 58.0 Flow 70.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EQ +12.0% INMB -40.39% Spread: +52.39 pp (EQ Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EQ Revenue INMB Revenue EQ Op. Margin INMB Op. Margin Margin Edge
FY2020 N/A $0M N/A -111163.6% INMB
FY2021 N/A $0M N/A -16106.6% INMB
FY2022 $20M $0M -393.9% -6938.8% EQ
FY2023 $40M $0M -40.2% -19187.7% EQ
FY2024 $40M $0M -20.1% -304535.7% EQ
FY2025 N/A $0M N/A -94766.0% INMB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EQ (6) vs INMB (2)
Institutional Metric EQ INMB Criterion Row Winner
Market Capitalization Scale $90.6M $31.9M Larger Scale EQ
Trailing P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Forward P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Revenue Growth (YoY) Growth -52.3% +257.1% Higher Growth INMB
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -59.0% -76.7% Higher ROE EQ
52-Week Range Position Momentum 11% ($1โ€“$4) 0% ($1โ€“$3) Stronger Trend EQ
Beta / 30D Volatility Risk Regime 1.53ฮฒ ยท 93% Vol 2.70ฮฒ ยท 85% Vol Lower Realized Risk INMB
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 45.4 / 100 (HOLD) Higher Composite EQ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EQ vs INMB Buy Guide
EQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
INMB BREAKDOWN
52d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 61st %ile
IV Regime Elevated (60thโ€“80th %ile)
Live INMB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EQ nor INMB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.